<DOC>
	<DOCNO>NCT00503763</DOCNO>
	<brief_summary>The aim study evaluate effect statin administration course progressive Smoldering Multiple Myeloma .</brief_summary>
	<brief_title>Efficacy Safety Statin Course Progressive Smoldering Multiple Myeloma</brief_title>
	<detailed_description>In vitro data indicate statin affect myeloma cell , mainly induce cell death growth suppression . This national , multicenter , phase IIa , single arm ( control ) , open label clinical trial Simvastatin 80mg p.o . /day population patient progressive SMM . Patients treat Simvastatin 40 mg side effect see dose escalated 80 mg 18 month . All treatment decision completion study discretion investigator.Approximately 15 patient enrol .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1 . Patients fulfil criterion SMM . ( see Appendix I ) 2 . Patients progressive smolder Myeloma . ( see Appendix II ) 3 . Age 1880 year . 4 . Signed informed consent prior patient recruitment . 1 . Patients fulfil diagnostic criterion active MM . ( see Appendix I ) 2 . Patients fulfil diagnostic criterion : solitary myeloma non secrete myeloma oligosecretory myeloma light chain myeloma . 3 . Patients statin treatment day recruitment . 4 . Patients chemotherapy receive steroid . 5 . Patients contraindication statin treatment : Known intolerance hypersensitivity statin . SGOT SGPT 1.5 time upper normal level ( UNL ) . CPK UNL Concomitant treatment macrolides antifungal agent ( ketoconazole ) Creatinine level 1.5 mg % Any severe and/or uncontrolled medical disease ( i.e. , uncontrolled diabetes , chronic renal disease , active uncontrolled infection ) . 6 . Patients second primary malignancy ( except non melanoma skin malignancy ) unless disease free least five year . 7 . Patients history alcohol drug abuse . 8 . Patients mentally physically unable comply aspect study . 9 . Participation investigational drug trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Smoldering multiple myeloma</keyword>
	<keyword>Simvastatin</keyword>
	<keyword>Paraprotein</keyword>
</DOC>